AJANTA PHARMA
Back to Income Statement
|
AJANTA PHARMA Last 5 Year Revenue History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Net Sales | ₹3,341 Cr | ₹2,890 Cr | ₹2,588 Cr | ₹2,055 Cr | ₹2,126 Cr |
What is the latest Revenue of AJANTA PHARMA ?
Year | Revenue |
---|---|
Mar2023 | ₹3,341 Cr |
Mar2022 | ₹2,890 Cr |
Mar2021 | ₹2,588 Cr |
Mar2020 | ₹2,055 Cr |
Mar2019 | ₹2,126 Cr |
How is Revenue of AJANTA PHARMA Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2023 | ₹3,341 Cr | 15.62 | |
Mar2022 | ₹2,890 Cr | 11.66 | |
Mar2021 | ₹2,588 Cr | 25.91 | |
Mar2020 | ₹2,055 Cr | -3.31 | |
Mar2019 | ₹2,126 Cr | - |
Compare Revenue of peers of AJANTA PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AJANTA PHARMA | ₹27,820.1 Cr | 3.5% | -0.4% | 70.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,167.0 Cr | 2.6% | -4.7% | 54.7% | Stock Analytics | |
CIPLA | ₹113,645.0 Cr | 4.4% | -4.4% | 54.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,890.0 Cr | 5.8% | 17.7% | 24.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,987.0 Cr | 5.7% | 2.7% | 29.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,950.6 Cr | 0.4% | -5.4% | 82.7% | Stock Analytics |
AJANTA PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AJANTA PHARMA | 3.5% |
-0.4% |
70.9% |
SENSEX | 1.4% |
2.5% |
24.3% |
You may also like the below Video Courses